Cargando…

miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB

Resistance to tamoxifen is a major clinical challenge. Research in recent years has identified epigenetic changes as mediated by dysregulated miRNAs that can possibly play a role in resistance to tamoxifen in breast cancer patients expressing estrogen receptor (ER). We report here elevated levels of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yu, Zhang, Wenzhi, Liu, Chengwen, Li, Guanghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906507/ https://www.ncbi.nlm.nih.gov/pubmed/31827114 http://dx.doi.org/10.1038/s41598-019-54289-6

Ejemplares similares

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
por: Cittelly, Diana M, et al.
Publicado: (2010)

Tamoxifen reverses epithelial–mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells
por: Wang, Qian, et al.
Publicado: (2017)

Exosomes Mediated Transfer of Circ_UBE2D2 Enhances the Resistance of Breast Cancer to Tamoxifen by Binding to MiR-200a-3p
por: Hu, Ke, et al.
Publicado: (2020)

Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer
por: Meng, Xiaodan, et al.
Publicado: (2016)

CD63(+) Cancer‐Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR‐22
por: Gao, Yuan, et al.
Publicado: (2020)

Circulating miR-200c and miR-141 and outcomes in patients with breast cancer
por: Antolín, Silvia, et al.
Publicado: (2015)

miR-489 Confines Uncontrolled Estrogen Signaling through a Negative Feedback Mechanism and Regulates Tamoxifen Resistance in Breast Cancer
por: Soni, Mithil, et al.
Publicado: (2022)

miR-150 Suppresses Tumor Growth in Melanoma Through Downregulation of MYB
por: Sun, Xiyan, et al.
Publicado: (2019)

SAT-LB130 Tamoxifen Affects MiRNA Expression in Uterus and Breast Tamoxifen Affects MiRNA Expression in Uterus and Breast Tamoxifen Affects MiRNA Expression in Uterus and Breast
por: Gulyaeva, Lyudmila, et al.
Publicado: (2020)

Regulation of miR‐200c and miR‐141 by Methylation in Prostate Cancer
por: Lynch, Seodhna M., et al.
Publicado: (2016)

MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy
por: Yu, Xinfeng, et al.
Publicado: (2015)

MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer
por: Tian, Yao, et al.
Publicado: (2023)

Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4
por: Ahmad, Aamir, et al.
Publicado: (2015)

LncRNA SNHG6 sponges miR-101 and induces tamoxifen resistance in breast cancer cells through induction of EMT
por: Khan, Mohammad Imran, et al.
Publicado: (2022)

miR828 and miR858 regulate VvMYB114 to promote anthocyanin and flavonol accumulation in grapes
por: Tirumalai, Varsha, et al.
Publicado: (2019)

ELOVL2-AS1 suppresses tamoxifen resistance by sponging miR-1233-3p in breast cancer
por: Kim, Hyeon Woo, et al.
Publicado: (2023)

CRKL oncogene is downregulated by p53 through miR-200s
por: Tamura, Miyuki, et al.
Publicado: (2015)

The miR-200 family in ovarian cancer
por: Koutsaki, Maria, et al.
Publicado: (2017)

ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer
por: Duhachek-Muggy, Sara, et al.
Publicado: (2015)

Regulation of MYB mediated cisplatin resistance of ovarian cancer cells involves miR-21-wnt signaling axis
por: Zhang, Xue-yan, et al.
Publicado: (2020)

miR-200 family promotes podocyte differentiation through repression of RSAD2
por: Li, Zhigui, et al.
Publicado: (2016)

miR-221/222 sponge abrogates tamoxifen resistance in ER-positive breast cancer cells through restoring the expression of ERα
por: Ouyang, Yan Xiu, et al.
Publicado: (2021)

The role of miR-200 family in the regulation of hallmarks of cancer
por: Klicka, Klaudia, et al.
Publicado: (2022)

LncRNA BC200/miR-150-5p/MYB positive feedback loop promotes the malignant proliferation of myelodysplastic syndrome
por: Liu, Zhaoping, et al.
Publicado: (2022)

The Kindlin-2 regulation of epithelial-to-mesenchymal transition in breast cancer metastasis is mediated through miR-200b
por: Sossey-Alaoui, Khalid, et al.
Publicado: (2018)

miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer
por: HE, YUE-JUN, et al.
Publicado: (2013)

miR-200c inhibits breast cancer proliferation by targeting KRAS
por: Song, Cailu, et al.
Publicado: (2015)

Combined analysis of miR-200 family and its significance for breast cancer
por: Fontana, Andrea, et al.
Publicado: (2021)

MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion
por: Ast, Volker, et al.
Publicado: (2018)

Down-Regulation of miR-200c and Up-Regulation of miR-30c Target both Stemness and Metastasis Genes in Breast Cancer
por: Rahimi, Mahsa, et al.
Publicado: (2020)

Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells
por: Zhang, Xiumei, et al.
Publicado: (2019)

MiR-200c and HuR in ovarian cancer
por: Prislei, Silvia, et al.
Publicado: (2013)

Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p
por: Liu, Jianhui, et al.
Publicado: (2021)

CCAR1 5′ UTR as a natural miRancer of miR-1254 overrides tamoxifen resistance
por: Li, Gaopeng, et al.
Publicado: (2016)

HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503
por: Gorbatenko, Andrej, et al.
Publicado: (2019)

The miR-200 family: multiple effects on gliomas
por: Peng, Lilei, et al.
Publicado: (2018)

Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling
por: Tang, X, et al.
Publicado: (2016)

UTMD inhibit EMT of breast cancer through the ROS/miR-200c/ZEB1 axis
por: Shi, Dandan, et al.
Publicado: (2020)

miR-200b and miR-200c co-contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases
por: Liu, Jue, et al.
Publicado: (2019)

Evaluation of miR-141, miR-200c, miR-30b Expression and Clinicopathological Features of Bladder Cancer
por: Mahdavinezhad, Ali, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9i3eq2mmbc85ecm7uf29ioa9tk